RecruitingNot applicableNCT04654000

Rheopheresis as Adjuvant Treatment of Calciphylaxis

Studying Calciphylaxis

Last synced from ClinicalTrials.gov May 5, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: University Hospital, Lille
Principal Investigator: Arnaud Lionet, MD
University Hospital, Lille
Intervention: Rheopheresis procedure(procedure)
Enrollment: 138 enrolled
Eligibility: 18 years · All sexes
Timeline: 2023 – 2027

Study locations (29)

CHU d'Angers, Angers, France
CHU d'Arras, Arras, France
CHU d'Auxerre, Auxerre, France
CHU de Besançon, Hôpital Jean Minjoz, Besançon, France
CH de Béthune, Béthune, France
CH de Boulogne sur Mer, Boulogne-sur-Mer, France
CHU de Bordeaux, Bourdeaux, France
CHRU de Brest, Brest, France
CHU de Caen, Caen, France
Hôpital Nord Michallon, CHU de Grenoble, Grenoble, France
Centre ECHO Laval, Laval, France
Centre ECHO Le Mans, Le Mans, France
Hôpital Privé La Louvière, Lille, France
Hop Claude Huriez Chu Lille, Lille, France
CHR de Limoges, Limoges, France
+14 more locations on ClinicalTrials.gov

Collaborators

Direction Générale de l'Offre de Soins

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04654000 on ClinicalTrials.gov

Other trials for Calciphylaxis

Additional recruiting or active studies for the same condition.

See all trials for Calciphylaxis →

← Back to all trials